GH Research PLC (GHRS)

Currency in USD
16.77
+0.43(+2.63%)
Closed·
16.770.00(0.00%)
·
GHRS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.5117.10
52 wk Range
8.5119.51
Key Statistics
Prev. Close
16.77
Open
16.51
Day's Range
16.51-17.1
52 wk Range
8.51-19.51
Volume
83.24K
Average Volume (3m)
198.62K
1-Year Change
86.5406%
Book Value / Share
4.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GHRS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
39.25
Upside
+134.05%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

GH Research PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company’s lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Compare GHRS to Peers and Sector

Metrics to compare
GHRS
Peers
Sector
Relationship
P/E Ratio
−21.6x−3.6x−0.5x
PEG Ratio
3.880.000.00
Price/Book
3.7x3.1x2.6x
Price / LTM Sales
-172.7x3.2x
Upside (Analyst Target)
117.3%238.3%47.6%
Fair Value Upside
Unlock16.9%6.1%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 39.25
(+134.05% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy34.00+102.74%29.00MaintainMar 10, 2026
Needham
Buy32.00+90.82%31.00MaintainMar 06, 2026
Citizens
Buy42.00+150.45%39.00MaintainMar 06, 2026
RBC Capital
Buy40.00+138.52%33.00MaintainJan 23, 2026
Needham
Buy29.00+72.93%19.00MaintainJan 06, 2026

Earnings

Latest Release
Mar 05, 2026
EPS / Forecast
-0.23 / -0.27
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GHRS Income Statement

People Also Watch

5.75
CMPS
-0.35%
3.850
ATAI
+1.58%
9.400
ONDS
-0.74%
524.99
MDGL
-0.13%

FAQ

What Is the GH Research (GHRS) Stock Price Today?

The GH Research stock price today is 16.77 USD.

What Stock Exchange Does GH Research Trade On?

GH Research is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for GH Research?

The stock symbol for GH Research is "GHRS."

What Is the GH Research Market Cap?

As of today, GH Research market cap is 1.04B USD.

What Is GH Research's Earnings Per Share (TTM)?

The GH Research EPS (TTM) is -0.79.

When Is the Next GH Research Earnings Date?

GH Research will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is GHRS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has GH Research Stock Split?

GH Research has split 0 times.

How Many Employees Does GH Research Have?

GH Research has 73 employees.

What is the current trading status of GH Research (GHRS)?

As of Apr 15, 2026, GH Research (GHRS) is trading at a price of 16.77 USD, with a previous close of 16.77 USD. The stock has fluctuated within a day range of 16.51 USD to 17.10 USD, while its 52-week range spans from 8.51 USD to 19.51 USD.

What Is GH Research (GHRS) Price Target According to Analysts?

The average 12-month price target for GH Research is 39.25 USD, with a high estimate of 70 USD and a low estimate of 25 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +134.05% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.